Inflammatory Bowel Disease (IBD) Therapeutics: Global Strategic Business Report

Global Inflammatory Bowel Disease (IBD) Therapeutics Market to Reach $32.8 Billion by 2030

The global market for Inflammatory Bowel Disease (IBD) Therapeutics estimated at US$23.2 Billion in the year 2022, is projected to reach a revised size of US$32.8 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2022-2030. TNF inhibitors, one of the segments analyzed in the report, is projected to record 5.5% CAGR and reach US$14 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Anti-integrin segment is readjusted to a revised 4.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.3 Billion, While China is Forecast to Grow at 8.7% CAGR

The Inflammatory Bowel Disease (IBD) Therapeutics market in the U.S. is estimated at US$6.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Select Competitors (Total 69 Featured) -

• 4SC AG
• Abbott Nutrition
• AbbVie, Inc.
• Ablynx NV
• Active Biotech AB
• Alfasigma S.p.A.
• Allergan PLC
• Allergan PLC
• Amgen, Inc.
• Astellas Pharma, Inc.
• AstraZeneca PLC
• Athersys, Inc.
• Atlantic Healthcare plc
• Avaxia Biologics, Inc.
• Biosafe Systems, LLC
• Boehringer Ingelheim GmbH
• Cadila Healthcare Ltd.
• Celgene Corporation
• Celltrion, Inc.
• Cipla Ltd.
• Coherus Biosciences, Inc.
• Cosmo Pharmaceuticals NV
• Dr. Falk Pharma GmbH
• EA Pharma Co., Ltd.
• Eddingpharm
• EPIRUS Biopharmaceuticals, Inc.
• F. Hoffmann-La Roche AG
• F. Hoffmann-La Roche AG
• Galapagos NV
• Giaconda Ltd.
• Google LLC
• Immunic, Inc.
• InDex Pharmaceuticals Holding AB
• Infinity Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.
• Janssen Biotech, Inc.
• Johnson & Johnson
• Kissei Pharmaceutical Co., Ltd.
• LG Sciences
• Lupin Ltd.
• Mochida Pharmaceutical Co., Ltd.
• Mylan Pharmaceutical Pvt. Ltd.
• Neovacs SA
• Nogra Pharma Limited
• NovaMedica LLC
• Novartis International AG
• Osiris Therapeutics, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• PAR Pharmaceutical Companies, Inc.
• PendoPharm, Inc.
• Perrigo Company PLC
• Pfenex, Inc.
• Pfizer, Inc.
• Pharmascience Inc.
• Pluristem Therapeutics, Inc.
• Qu Biologics Inc.
• Quest Diagnostics, Inc.
• RedHill Biopharma Ltd.
• Reliance Life Sciences
• Salix Pharmaceuticals, Inc.
• Sandoz International GmbH
• Sanofi
• Sequella, Inc.
• Soligenix, Inc.
• Takeda Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• Toray Industries, Inc.
• Torrent Pharmaceuticals Ltd.
• UCB SA
• Zeria Pharmaceutical Co., Ltd.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year